Biotechnology News SOLIRIS Search

| Biotechnology feed | All feeds

BioNews
Biotechnology, Pharmaceutical and Life Science News

Search Results

Documents 1-5 out of 5 found

Current Search: soliris: 5

Manufacturing news in brief
Pharmafocus' round-up of developments in pharmaceutical manufacturing includes facility updates from Dishman, Alexion, Stirling Products, RL Fine Chemicals and Cambrex, as well as a Dow spin-out and catalyst deal for Codexis.

Dishman Netherlands has opened a...

Pharmafocus: Dec 31 2009 10:08PM
Matching: soliris

Find similar documents

Soliris Reduced Hemolysis, Lowered Thrombosis Rate and Improved Quality of Life in Patients with PNH Who Had P
Data Presented at ASH Annual Meeting Indicate that Transfusion Requirements and Hemoglobin Levels May Not Adequately Reflect Morbidities of PNH Abstract 4029, Poster Board III-965 CHESHIRE, Conn.--(BUSINESS WIRE)--Dec 7, 2009 - New data presented today...

Pharma Live: Dec 7 2009 9:32PM
Matching: soliris

Find similar documents

Soliris Reversed Thrombocytopenia in Patients with Both PNH and Pre-Existing Thrombocytopenia in Study Present
Data Highlight Likely Ongoing Platelet Consumption in Untreated PNH Patients Abstract 4030, Poster Board III-966 CHESHIRE, Conn.--(BUSINESS WIRE)--Dec 7, 2009 - Soliris (eculizumab), a first-in-class terminal complement inhibitor developed by (Nasdaq:...

Pharma Live: Dec 7 2009 9:31PM
Matching: soliris

Find similar documents

Alexion Reports Progress on Commissioning of Rhode Island Manufacturing Facility as Second Source of Supply
CHMP Issues Positive Opinion for European Union; FDA Review Ongoing CHESHIRE, Conn.--(BUSINESS WIRE)--Dec 2, 2009 - Alexion Pharmaceuticals, Inc.

(Nasdaq: ALXN) today provided updates on the regulatory review and approval, or commissioning, of Alexion's Rhode...

Pharma Live: Dec 2 2009 2:13PM
Matching: soliris

Find similar documents

Alexion Appoints William R. Keller to its Board of Directors
About William Keller Mr.

Keller brings more than 30 years of international business and management experience in the pharmaceutical industry to his position on Alexions Board of Directors.

Currently, Mr.

Keller is the General Manager of Keller Pharma...

Stockwatch: Dec 1 2009 9:45PM
Matching: soliris

Find similar documents

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.